Cancer cells co-opt nociceptive nerves to thrive in nutrient-poor environments and upon nutrient-starvation therapies
Cancer cells co-opt nociceptive nerves to thrive in nutrient-poor environments and upon nutrient-starvation therapies
复制标题
癌细胞利用伤害性神经在营养贫乏的环境和营养饥饿疗法中茁壮成长
DOI:
10.1016/j.cmet.2022.10.012
复制
发表时间:
2022
期刊:
影响因子:
29
通讯作者:
Tong Ji
中科院分区:
文献类型:
--
作者:
Yu Zhang;Chengzhong Lin;Zheqi Liu;Yiting Sun;Mingtao Chen;Yibo Guo;Wei Liu;Chenping Zhang;Wantao Chen;Jian Sun;Ronghui Xia;Yuhua Hu;Xi Yang;Jiang Li;Zhiyuan Zhang;Wei Cao;Shuyang Sun;Xu Wang;Tong Ji
Although nutrient-starvation therapies can elicit strong anti-tumor effects in multiple carcinomas, it has been convincingly demonstrated that cancer cells exploit the tumor microenvironment to thrive in nutrient-poor environments. Here, we reveal that cancer cells can co-opt nociceptive nerves to thrive in nutrient-poor environments. Initially examining the low-glucose environment of oral mucosa carcinomas, we discovered that cancer cells employ ROS-triggered activation of c-Jun to secrete nerve growth factor (NGF), which conditions nociceptive nerves for calcitonin gene-related peptide (CGRP) production. The neurogenic CGRP subsequently induces cytoprotective autophagy in cancer cells through Rap1-mediated disruption of the mTOR-Raptor interaction. Both anti-glycolysis and anti-angiogenesis-based nutrient-starvation therapies aggravate the vicious cycle of cancer cells and nociceptive nerves and therapeutically benefit from blocking neurogenic CGRP with an FDA-approved antimigraine drug. Our study sheds light on the role of the nociceptive nerve as a microenvironmental accomplice of cancer progression in nutrient-poor environments and upon nutrient-starvation therapies.